Jiangsu Hengrui Medicine Co., Ltd.

This study tested a combination of three drugs—SHR-1210, famitinib, and chemotherapy—in people with advanced non-squamous lung cancer that had not been treated before. The goal was to see if the combo could slow cancer growth and be safe. The trial was stopped early and included …

This study tested whether adding the drug SHR3680 to standard hormone therapy could improve outcomes for men with high-risk prostate cancer before they had surgery to remove the prostate. The trial enrolled 391 participants and aimed to see if the combination could eliminate all …

This study tested an experimental inhaled medicine called HRG2005 in people with moderate to severe chronic obstructive pulmonary disease (COPD). The goal was to see if it improves lung function compared to an active control. About 200 adults aged 40 and older with a history of C…